TY - JOUR
T1 - Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis
AU - Ito, Akihiko
AU - Mimae, Takahiro
AU - Yamamoto, Ying Shan Zhu
AU - Hagiyama, Man
AU - Nakanishi, Jun
AU - Ito, Masaoki
AU - Hosokawa, Yoichiroh
AU - Okada, Morihito
AU - Murakami, Yoshinori
AU - Kondo, Tadashi
N1 - Funding Information:
This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, from the Nakatani Foundation of Electronic Measuring Technology Advancement, from the Ministry of Health, Labor and Welfare, and from the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan.
PY - 2012/9
Y1 - 2012/9
N2 - We developed a novel application to conduct pseudopodia proteomics. Pseudopodia are ventral actin-rich protrusions and play functional roles in cell migrations. Identification of pseudopodia proteins leads to a further understanding of malignant phenotypes of tumor cells and novel therapeutic strategies. In our application, tumor cells were placed on a fibronectin-coated porous membrane to form pseudopodia. According to the motile potentials of the cells, the cells formed pseudopodial microprocesses in the pores. An excimer laser, which was used for ophthalmic refractive surgeries, horizontally ablated cells at the membrane surface to remove the cell body. The microscopic observations and the protein expression studies suggested that the laser treatment caused no apparent damages to pseudopodia. Proteins in whole cells and pseudopodia fractions were individually solubilized, labeled with a highly sensitive fluorescent dye, and separated using two-dimensional difference gel electrophoresis. Among 2508 protein spots observed, 211 had different intensity between whole cells and pseudopodia fractions (more than fourfold differences and P-value of <0.05). The protein enrichment depended on the pore size. Mass spectrometric protein identification revealed 46 pseudopodia-localizing proteins. The localization of novel pseudopodia-localizing proteins such as RAB1A, HSP90B, TDRD7, and vimentin was confirmed using immunohistochemical examinations. The previous studies demonstrated that these four proteins may function in the cell migration process. This method will provide insights into the molecular details of pseudopodia and a further understanding of malignant phenotypes of tumor cells and novel therapeutic strategies.
AB - We developed a novel application to conduct pseudopodia proteomics. Pseudopodia are ventral actin-rich protrusions and play functional roles in cell migrations. Identification of pseudopodia proteins leads to a further understanding of malignant phenotypes of tumor cells and novel therapeutic strategies. In our application, tumor cells were placed on a fibronectin-coated porous membrane to form pseudopodia. According to the motile potentials of the cells, the cells formed pseudopodial microprocesses in the pores. An excimer laser, which was used for ophthalmic refractive surgeries, horizontally ablated cells at the membrane surface to remove the cell body. The microscopic observations and the protein expression studies suggested that the laser treatment caused no apparent damages to pseudopodia. Proteins in whole cells and pseudopodia fractions were individually solubilized, labeled with a highly sensitive fluorescent dye, and separated using two-dimensional difference gel electrophoresis. Among 2508 protein spots observed, 211 had different intensity between whole cells and pseudopodia fractions (more than fourfold differences and P-value of <0.05). The protein enrichment depended on the pore size. Mass spectrometric protein identification revealed 46 pseudopodia-localizing proteins. The localization of novel pseudopodia-localizing proteins such as RAB1A, HSP90B, TDRD7, and vimentin was confirmed using immunohistochemical examinations. The previous studies demonstrated that these four proteins may function in the cell migration process. This method will provide insights into the molecular details of pseudopodia and a further understanding of malignant phenotypes of tumor cells and novel therapeutic strategies.
KW - excimer laser ablation
KW - mass spectrometry
KW - proteome
KW - pseudopodia
KW - two-dimensional difference gel electrophoresis
UR - http://www.scopus.com/inward/record.url?scp=84865632779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865632779&partnerID=8YFLogxK
U2 - 10.1038/labinvest.2012.98
DO - 10.1038/labinvest.2012.98
M3 - Article
C2 - 22751350
AN - SCOPUS:84865632779
SN - 0023-6837
VL - 92
SP - 1374
EP - 1385
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 9
ER -